Literature DB >> 15234142

Long-term visual outcome of transscleral laser cyclotherapy in eyes with ambulatory vision.

Jacob T Wilensky1, Jeffrey Kammer.   

Abstract

OBJECTIVE: To determine the long-term visual acuity (VA) outcome of eyes with ambulatory vision (20/80 or better) that were treated with transscleral laser cyclotherapy.
DESIGN: Observational case series. PARTICIPANTS: Twenty-one eyes of 21 patients who had been treated with laser cyclotherapy and who had been followed up at least 1 year.
METHODS: A retrospective chart review was conducted to record the prelaser best-corrected VA and then the last available post laser VA and duration of follow-up. Additional laser or surgical interventions for glaucoma control were also recorded. MAIN OUTCOME MEASURES: Changes in VA from pretreatment to last available examination.
RESULTS: The 21 eyes were followed for a mean of 40.7 months (range, 13-88 months); 17 eyes had a final vision within 1 line of the prelaser VA. One eye improved 3 lines, and 3 eyes deteriorated 3 or more lines.
CONCLUSIONS: Most eyes with 20/80 or better VA maintained close to that acuity after laser cyclotherapy after a mean follow-up of 40.7 months. These good visual results offer support for those who believe that the indications for laser cyclotherapy should not be limited to eyes with poor VA or potential.

Entities:  

Mesh:

Year:  2004        PMID: 15234142     DOI: 10.1016/j.ophtha.2003.11.008

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Intermediate term safety and efficacy of transscleral cyclophotocoagulation after tube shunt failure.

Authors:  Peter J Ness; Mahmoud A Khaimi; Robert M Feldman; Rania Tabet; Steven R Sarkisian; Gregory L Skuta; Alice Z Chuang; Kimberly A Mankiewicz
Journal:  J Glaucoma       Date:  2012-02       Impact factor: 2.503

2.  Transscleral Diode Laser Cyclophotocoagulation: A Comparison of Slow Coagulation and Standard Coagulation Techniques.

Authors:  Eric Rh Duerr; Mohamed S Sayed; Stephen Moster; Timothy Holley; Jin Peiyao; Elizabeth A Vanner; Richard K Lee
Journal:  Ophthalmol Glaucoma       Date:  2018-08-25

3.  A retrospective analysis of long-term outcomes following a single episode of transscleral cyclodiode laser treatment in patients with glaucoma.

Authors:  Ivailo Zhekov; Razia Janjua; Humma Shahid; Nicholas Sarkies; Keith R Martin; Andrew J R White
Journal:  BMJ Open       Date:  2013-07-06       Impact factor: 2.692

4.  Transscleral cyclophotocoagulation followed by cataract surgery: a novel protocol to treat refractory acute primary angle closure.

Authors:  Wei Liu; Luning Qin; Chenjia Xu; Dandan Huang; Ruru Guo; Jian Ji; Nomdo M Jansonius
Journal:  BMC Ophthalmol       Date:  2020-05-29       Impact factor: 2.209

5.  Comparison of Outcomes between Endoscopic and Transcleral Cyclophotocoagulation.

Authors:  Robert Beardsley; Simon K Law; Joseph Caprioli; Anne L Coleman; Kouros Nouri-Mahdavi; Jean-Pierre Hubschman; Steven D Schwartz; JoAnn A Giaconi
Journal:  Vision (Basel)       Date:  2017-11-06

6.  First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma.

Authors:  Enrico Bernardi; Marc Töteberg-Harms
Journal:  Int Ophthalmol       Date:  2022-02-03       Impact factor: 2.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.